Patent ID: 7393840
Filing Date: 2008-07-01
Classification: A61K,A61P

Abstract:
1. A solid or semisolid formulation, comprising i) 5-40% by weight of an active ingredient component containing at least heparin, glycosaminoglycan or heparinoid, and optionally at least one other active ingredient; ii) a lipid component containing at least one lipid, wherein the lipid component has a hydrophilic-lipophilic balance not exceeding 8; 10-80% by weight of a solid polymer component containing one or more polymers selected from the group consisting of a polyvinylpyrrolidone, a vinylpyrrolidone/vinylacetate copolymer, a hydroxyalkylcellulose, a hydroxyalkylalkylcellulose, a cellulose phthalate and a (meth)acrylic resin; and iv. optionally, at least one pharmaceutically acceptable excipient, and provided that and wherein the formulation does not contain a surface active excipient having a hydrophilic-lipophilic balance of more than 10.